VRTX : Summary for Vertex Pharmaceuticals Incorpor - Yahoo Finance

U.S. Markets open in 6 hrs 5 mins

Vertex Pharmaceuticals Incorporated (VRTX)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
90.04+0.54 (+0.60%)
At close: 4:00PM EDT
People also watch
ALXNREGNBMRNINCYBIIB
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close89.50
Open89.95
Bid75.70 x 100
Ask0.00 x
Day's Range89.06 - 90.25
52 Week Range71.46 - 103.73
Volume1,337,153
Avg. Volume1,627,330
Market Cap22.37B
Beta2.08
PE Ratio (TTM)-195.74
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals6 days ago

    Inside the small Norwood biotech that's making investors swoon

    The top-performing public biotech in Massachusetts over the past year is located in a nondescript brick building with no signage, located along a stretch of highway in Norwood that is better known for its car dealerships than drug developers. Investors in Corbus Pharmaceuticals (CRBP) don’t much seem to mind. The company believes that its anti-inflammatory treatment — initially under the generic name of "resunab" but recently renamed "anabasum" — could treat several rare disorders.

  • Zacks7 days ago

    Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals

    Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals

  • American City Business Journals8 days ago

    Once paid by Vertex, Trump's FDA pick would be tasked with regulating it

    President Donald Trump’s pick to lead the FDA is coming under scrutiny for his deep financial ties to drugmakers like Boston-based Vertex Pharmaceuticals, which critics warn could pose conflicts of interest. Scott Gottlieb, a former FDA official and a fellow at conservative think tank American Enterprise Institute who was nominated on Friday, received around $414,000 from drug companies between 2013 and 2015, according to public records. The exact nature of Gottlieb’s work for Vertex is not clear from the public records, which are posted on the Centers for Medicare and Medicaid Services website and only date back to 2013.